Literature DB >> 25738250

Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report.

Kai-Uwe Eckardt1, Seth L Alper2, Corinne Antignac3,4, Anthony J Bleyer5, Dominique Chauveau6, Karin Dahan7, Constantinos Deltas8, Andrew Hosking9, Stanislav Kmoch10, Luca Rampoldi11, Michael Wiesener1, Matthias T Wolf12, Olivier Devuyst13.   

Abstract

Rare autosomal dominant tubulointerstitial kidney disease is caused by mutations in the genes encoding uromodulin (UMOD), hepatocyte nuclear factor-1β (HNF1B), renin (REN), and mucin-1 (MUC1). Multiple names have been proposed for these disorders, including 'Medullary Cystic Kidney Disease (MCKD) type 2', 'Familial Juvenile Hyperuricemic Nephropathy (FJHN)', or 'Uromodulin-Associated Kidney Disease (UAKD)' for UMOD-related diseases and 'MCKD type 1' for the disease caused by MUC1 mutations. The multiplicity of these terms, and the fact that cysts are not pathognomonic, creates confusion. Kidney Disease: Improving Global Outcomes (KDIGO) proposes adoption of a new terminology for this group of diseases using the term 'Autosomal Dominant Tubulointerstitial Kidney Disease' (ADTKD) appended by a gene-based subclassification, and suggests diagnostic criteria. Implementation of these recommendations is anticipated to facilitate recognition and characterization of these monogenic diseases. A better understanding of these rare disorders may be relevant for the tubulointerstitial fibrosis component in many forms of chronic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25738250     DOI: 10.1038/ki.2015.28

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  59 in total

1.  Uromodulin storage disease.

Authors:  S H Nasr; J P Lucia; S J Galgano; G S Markowitz; V D D'Agati
Journal:  Kidney Int       Date:  2007-11-14       Impact factor: 10.612

2.  Activation of the bumetanide-sensitive Na+,K+,2Cl- cotransporter (NKCC2) is facilitated by Tamm-Horsfall protein in a chloride-sensitive manner.

Authors:  Kerim Mutig; Thomas Kahl; Turgay Saritas; Michael Godes; Pontus Persson; James Bates; Hajamohideen Raffi; Luca Rampoldi; Shinichi Uchida; Carsten Hille; Carsten Dosche; Satish Kumar; Maria Castañeda-Bueno; Gerardo Gamba; Sebastian Bachmann
Journal:  J Biol Chem       Date:  2011-07-07       Impact factor: 5.157

3.  MUC1 mucin and trefoil factor 1 protein expression in renal cell carcinoma: correlation with prognosis.

Authors:  Sigurd Kraus; Paul D Abel; Christian Nachtmann; Hans-Jörg Linsenmann; Wolfgang Weidner; Gordon W H Stamp; Khurram S Chaudhary; Stephen E Mitchell; Folker E Franke; El-Nasir Lalani
Journal:  Hum Pathol       Date:  2002-01       Impact factor: 3.466

Review 4.  Rare inherited kidney diseases: challenges, opportunities, and perspectives.

Authors:  Olivier Devuyst; Nine V A M Knoers; Giuseppe Remuzzi; Franz Schaefer
Journal:  Lancet       Date:  2014-05-24       Impact factor: 79.321

5.  Cystic disease of renal medulla.

Authors:  W M Bennett; N Simon; K D Gardner
Journal:  Ann Intern Med       Date:  1971-06       Impact factor: 25.391

6.  Pseudodominant inheritance of nephronophthisis caused by a homozygous NPHP1 deletion.

Authors:  Julia Hoefele; Ahmet Nayir; Moumita Chaki; Anita Imm; Susan J Allen; Edgar A Otto; Friedhelm Hildebrandt
Journal:  Pediatr Nephrol       Date:  2011-01-22       Impact factor: 3.714

7.  Familial juvenile hyperuricemic nephropathy and autosomal dominant medullary cystic kidney disease type 2: two facets of the same disease?

Authors:  Karin Dahan; Arno Fuchshuber; Stavroula Adamis; Michèle Smaers; Sabine Kroiss; Guy Loute; Jean-Pierre Cosyns; Friedhelm Hildebrandt; Christine Verellen-Dumoulin; Yves Pirson
Journal:  J Am Soc Nephrol       Date:  2001-11       Impact factor: 10.121

8.  Chromosome 1 localization of a gene for autosomal dominant medullary cystic kidney disease.

Authors:  K Christodoulou; M Tsingis; C Stavrou; A Eleftheriou; P Papapavlou; P C Patsalis; P Ioannou; A Pierides; C Constantinou Deltas
Journal:  Hum Mol Genet       Date:  1998-05       Impact factor: 6.150

9.  MUC1 expression is correlated with nuclear grade and tumor progression in pT1 renal clear cell carcinoma.

Authors:  Xavier Leroy; Farid Zerimech; Laurent Zini; Marie-Christine Copin; Marie-Pierre Buisine; Bernard Gosselin; Jean-Pierre Aubert; Nicole Porchet
Journal:  Am J Clin Pathol       Date:  2002-07       Impact factor: 2.493

10.  Outcome of kidney transplantation in autosomal dominant medullary cystic kidney disease type 1.

Authors:  Christoforos Stavrou; C Constantinou Deltas; Tasos C Christophides; Alkis Pierides
Journal:  Nephrol Dial Transplant       Date:  2003-10       Impact factor: 5.992

View more
  104 in total

Review 1.  Hepatocyte Nuclear Factor 1β-Associated Kidney Disease: More than Renal Cysts and Diabetes.

Authors:  Jacobien C Verhave; Anneke P Bech; Jack F M Wetzels; Tom Nijenhuis
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

2.  Clinical, Genetic, and Urinary Factors Associated with Uromodulin Excretion.

Authors:  Stéphan Troyanov; Catherine Delmas-Frenette; Guillaume Bollée; Sonia Youhanna; Vanessa Bruat; Philip Awadalla; Olivier Devuyst; François Madore
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-18       Impact factor: 8.237

3.  Multiple unilateral subcapsular cortical hemorrhagic cystic disease of the kidney: CT and MRI findings and clinical characteristic.

Authors:  Kotaro Yoshida; Naoki Takahashi; Bernard F King; Akira Kawashima; Peter C Harris; Lynn D Cornell; Emilie Cornec-Le Gall; Dai Inoue; Ichiro Mizushima; Mitsuhiro Kawano; Eric Thervet; Paul René de Cotret; Vicente E Torres
Journal:  Eur Radiol       Date:  2019-02-26       Impact factor: 5.315

4.  Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease.

Authors:  Emilie Cornec-Le Gall; Rory J Olson; Whitney Besse; Christina M Heyer; Vladimir G Gainullin; Jessica M Smith; Marie-Pierre Audrézet; Katharina Hopp; Binu Porath; Beili Shi; Saurabh Baheti; Sarah R Senum; Jennifer Arroyo; Charles D Madsen; Claude Férec; Dominique Joly; François Jouret; Oussamah Fikri-Benbrahim; Christophe Charasse; Jean-Marie Coulibaly; Alan S Yu; Korosh Khalili; York Pei; Stefan Somlo; Yannick Le Meur; Vicente E Torres; Peter C Harris
Journal:  Am J Hum Genet       Date:  2018-04-26       Impact factor: 11.025

Review 5.  The UMOD Locus: Insights into the Pathogenesis and Prognosis of Kidney Disease.

Authors:  Olivier Devuyst; Cristian Pattaro
Journal:  J Am Soc Nephrol       Date:  2017-11-27       Impact factor: 10.121

6.  Uromodulin in the Bloodstream: Old Wine in a New Wineskin.

Authors:  Daniel Kraus; Christoph Wanner
Journal:  J Am Soc Nephrol       Date:  2017-06-07       Impact factor: 10.121

Review 7.  Endoplasmic reticulum stress and monogenic kidney diseases in precision nephrology.

Authors:  Sun-Ji Park; Yeawon Kim; Ying Maggie Chen
Journal:  Pediatr Nephrol       Date:  2018-08-11       Impact factor: 3.714

Review 8.  Practical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation.

Authors:  Alejandra M Mena-Gutierrez; Amber M Reeves-Daniel; Colleen L Jay; Barry I Freedman
Journal:  Transplantation       Date:  2020-01       Impact factor: 4.939

9.  Elevated urinary CRELD2 is associated with endoplasmic reticulum stress-mediated kidney disease.

Authors:  Yeawon Kim; Sun-Ji Park; Scott R Manson; Carlos Af Molina; Kendrah Kidd; Heather Thiessen-Philbrook; Rebecca J Perry; Helen Liapis; Stanislav Kmoch; Chirag R Parikh; Anthony J Bleyer; Ying Maggie Chen
Journal:  JCI Insight       Date:  2017-12-07

10.  Uromodulin, kidney function, cardiovascular disease, and mortality.

Authors:  Olivier Devuyst; Murielle Bochud
Journal:  Kidney Int       Date:  2015-11       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.